Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael D Decker

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
The Journal of Pediatrics|May 25, 2012
Immunogenicity and safety of 1 vs 2 doses of quadrivalent meningococcal conjugate vaccine in youth infected with human immunodeficiency virusJorge Lujan-Zilbermann, Meredith G Warshaw, Paige L Williams, et al.
The Pediatric Infectious Disease Journal|October 12, 2011
Safety and immunogenicity of quadrivalent meningococcal conjugate vaccine in 2- to 10-year-old human immunodeficiency virus-infected childrenGeorge K Siberry, Meredith G Warshaw, Paige L Williams, et al.
Infectious Diseases (London, England)|October 23, 2015
Highly differentiated human airway epithelial cells: a model to study host cell-parasite interactions in pertussisClaudia Guevara, Chengxian Zhang, Jennifer A Gaddy, et al.
The Journal of Infectious Diseases|February 17, 2018
Relative Vaccine Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among Veterans Health Administration PatientsYinong Young-Xu, Robertus Van Aalst, Salaheddin M Mahmud, et al.
The Pediatric Infectious Disease Journal|May 1, 2010
Phase I/II, open-label trial of safety and immunogenicity of meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine in human immunodeficiency virus-infected adolescentsGeorge K Siberry, Paige L Williams, Jorge Lujan-Zilbermann, et al.
Vaccine|November 26, 2011
Immune responses in adults to revaccination with a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine 10 years after a previous doseScott A Halperin, David Scheifele, Gaston De Serres, et al.
The New England Journal of Medicine|August 15, 2014
Efficacy of high-dose versus standard-dose influenza vaccine in older adultsCarlos A DiazGranados, Andrew J Dunning, Murray Kimmel, et al.
JAMA|December 18, 2003
Strengthening the supply of routinely recommended vaccines in the United States: recommendations from the National Vaccine Advisory CommitteeJeanne M Santoli, Georges Peter, Ann Margaret Arvin, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
The Journal of Pediatrics|May 25, 2012
Immunogenicity and safety of 1 vs 2 doses of quadrivalent meningococcal conjugate vaccine in youth infected with human immunodeficiency virusJorge Lujan-Zilbermann, Meredith G Warshaw, Paige L Williams, et al.
The Pediatric Infectious Disease Journal|October 12, 2011
Safety and immunogenicity of quadrivalent meningococcal conjugate vaccine in 2- to 10-year-old human immunodeficiency virus-infected childrenGeorge K Siberry, Meredith G Warshaw, Paige L Williams, et al.
Infectious Diseases (London, England)|October 23, 2015
Highly differentiated human airway epithelial cells: a model to study host cell-parasite interactions in pertussisClaudia Guevara, Chengxian Zhang, Jennifer A Gaddy, et al.
The Journal of Infectious Diseases|February 17, 2018
Relative Vaccine Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among Veterans Health Administration PatientsYinong Young-Xu, Robertus Van Aalst, Salaheddin M Mahmud, et al.
The Pediatric Infectious Disease Journal|May 1, 2010
Phase I/II, open-label trial of safety and immunogenicity of meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine in human immunodeficiency virus-infected adolescentsGeorge K Siberry, Paige L Williams, Jorge Lujan-Zilbermann, et al.
Vaccine|November 26, 2011
Immune responses in adults to revaccination with a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine 10 years after a previous doseScott A Halperin, David Scheifele, Gaston De Serres, et al.
The New England Journal of Medicine|August 15, 2014
Efficacy of high-dose versus standard-dose influenza vaccine in older adultsCarlos A DiazGranados, Andrew J Dunning, Murray Kimmel, et al.
JAMA|December 18, 2003
Strengthening the supply of routinely recommended vaccines in the United States: recommendations from the National Vaccine Advisory CommitteeJeanne M Santoli, Georges Peter, Ann Margaret Arvin, et al.
Pageof 5